Dual inhibition of MAPK signaling (MEK1/2 inhibition) and the mitotic pathway (PLK1 inhibition) synergistically reduced the outgrowth of both murine and human breast cancer cells. The gene discussed is PLK1; the disease is breast carcinoma.